HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine

Blood

Volumn 125, Issue 2, 2015, Pages 417-418

  Benajiba, Lina ^a   Salvado, Clementine ^b   Dalle, Jean Hugues ^c   Jubert, Charlotte ^d   Galambrun, Claire ^a   Soulier, Jean ^e   Socié, Gerard ^a   De Latour, Regis Peffault ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^e UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HEMOGLOBIN; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; VIDARABINE;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BONE MARROW CELL; CHEMOPROPHYLAXIS; CHILD; CHROMOSOME ABERRATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLONAL EVOLUTION; ENGRAFTMENT; FANCONI ANEMIA; FOLLOW UP; GRAFT FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LOW DRUG DOSE; MUCOSA INFLAMMATION; NEUTROPHIL; OVERALL SURVIVAL; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SIBLING; STEM CELL; SURVIVAL RATE; T CELL DEPLETION; THROMBOCYTE; TOXOPLASMOSIS; TREATMENT INDICATION; UMBILICAL CORD BLOOD; ANALOGS AND DERIVATIVES; FEMALE; HISTOCOMPATIBILITY TEST; IMMUNOSUPPRESSIVE TREATMENT; MALE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; CHILD; CYCLOPHOSPHAMIDE; FANCONI ANEMIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; TRANSPLANTATION CONDITIONING; VIDARABINE; YOUNG ADULT;

EID: 84921047833     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-10-605113     Document Type: Article

References (10)

1. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101(4):1249-1256.
2. Gluckman E, Auerbach AD, Horowitz MM, et al. Bone marrow transplantation for Fanconi anemia. Blood. 1995;86(7):2856-2862.
3. Peffault de Latour R, Porcher R, Dalle JH, et al; FA Committee of the Severe Aplastic Anemia Working Party; Pediatric Working Party of the European Group for Blood and Marrow Transplantation. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood. 2013;122(26):4279-4286.
4. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol. 1983;54(3):431-440.
5. Medeiros C, Zanis-Neto J, Pasquini R. Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning. Bone Marrow Transplant. 1999;24(8):849-852.
6. de la Fuente J, Reiss S, McCloy M, et al. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors. Bone Marrow Transplant. 2003;32(7):653-656.
7. Locatelli F, Zecca M, Pession A, et al; Italian pediatric group. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group. Haematologica. 2007;92(10):1381-1388.
8. Shimada A, Takahashi Y, Muramatsu H, et al. Excellent outcome of allogeneic bone marrow transplantation for Fanconi anemia using fludarabine-based reduced-intensity conditioning regimen. Int J Hematol. 2012;95(6):675-679.
9. Stepensky P, Shapira MY, Balashov D, et al. Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning. Biol Blood Marrow Transplant. 2011;17(9):1282-1288.
10. Bonfim CM, de Medeiros CR, Bitencourt MA, et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide. Biol Blood Marrow Transplant. 2007;13(12):1455-1460.